Deutsche Bank’s $ 101 goal
- Shares of CVS Health Corp (NYSE: CVS) received a price target increase from $ 95 to $ 101 from Deutsche Bank. These are the details.
Shares of CVS Health Corp (NYSE: CVS) received a price target increase from $ 95 to $ 101 from Deutsche Bank. And Deutsche Bank analyst George Hill maintains a “Buy” rating on the company’s shares after strong second quarter results.
Highlights for the second quarter include total revenue up to $ 72.6 million, up 11.1% from the previous year. GAAP diluted EPS was $ 2.10 and adjusted EPS was $ 2.42.
Since the start of the year, total revenues have increased to $ 141.7 billion, up 7.3% from the previous year. And GAAP diluted EPS was $ 3.78 and Adjusted EPS was $ 4.46. The company generated $ 8.7 billion in operating cash flow and repaid $ 5.4 billion in long-term debt.
With respect to the annual forecast, the Company increased the range of forecast diluted GAAP EPS from $ 6.35 to $ 6.45, from $ 6.24 to $ 6.36. And they increased the forecast range for Adjusted EPS from $ 7.70 to $ 7.80, from $ 7.56 to $ 7.68. Additionally, cash flow forecast from operations ranges from $ 12.5 billion to $ 13 billion from $ 12 to 12.5 billion
Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.